TRPML1 and RAS-driven Cancers – Exploring a Link With Great Therapeutic Potential

Channels - United States
doi 10.1080/19336950.2019.1666457
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited